Massachusetts Financial Services’s CG Oncology CGON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.26M Sell
136,841
-65,077
-32% -$3.69M ﹤0.01% 732
2025
Q4
$8.38M Sell
201,918
-45,831
-18% -$1.9M ﹤0.01% 723
2025
Q3
$9.98M Sell
247,749
-1,915
-0.8% -$55.7K ﹤0.01% 690
2025
Q2
$6.49M Sell
249,664
-8,426
-3% -$203K ﹤0.01% 700
2025
Q1
$6.32M Buy
258,090
+933
+0.4% +$26.2K ﹤0.01% 685
2024
Q4
$7.38M Sell
257,157
-22,788
-8% -$780K ﹤0.01% 667
2024
Q3
$10.6M Buy
279,945
+13,158
+5% +$461K ﹤0.01% 638
2024
Q2
$8.42M Buy
266,787
+6,899
+3% +$239K ﹤0.01% 655
2024
Q1
$11.4M Buy
+259,888
New +$10.6M ﹤0.01% 617

Other funds holding CGON